Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01907061 · ClinicalTrials.gov registry record · NA
Acute Renal Failure Post Liver Transplantation
A NA study of Acute Renal Failure, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01907061: Completed NA study of Acute Renal Failure, sponsored by Baylor Research Institute.
NCT01907061 is a NA study of Acute Renal Failure that has completed, run by Baylor Research Institute. The registered enrollment target is 30 participants, below the 262-participant average among 5 other Acute Renal Failure trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01907061, a NA study of Acute Renal Failure, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Trial to test the effect of administering N-acetylcysteine on cytokines and markers of oxidant stress and the incidence of acute renal failure post liver tranplant
Primary Outcome
Cytokines in patients receiving N-acetylcysteine versus those receiving placebo during liver transplantation will be compared.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG N-acetylcysteine
Study Locations (1)
Texas
- Annette C. and Harold C. Simmons Tranplant Institute at Baylor Medical Center Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT01907061 record still lists
NCT01907061 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 262-participant average among 5 other Acute Renal Failure trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Acute Renal Failure appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01907061 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01907061 about?
NCT01907061 is a clinical study titled "Acute Renal Failure Post Liver Transplantation". Trial to test the effect of administering N-acetylcysteine on cytokines and markers of oxidant stress and the incidence of acute renal failure post liver tranplant
What is the current status of trial NCT01907061?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2007-07. Estimated completion is 2014-07.
What conditions does trial NCT01907061 study?
This clinical trial studies the following conditions: Acute Renal Failure.
What interventions are being tested in trial NCT01907061?
The interventions under investigation include: Placebo (DRUG), N-acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT01907061?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01907061 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Renal Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes?
COMPLETED · NA
-
Low Dose Thymoglobin in Renal Transplant Patients
COMPLETED · NA
-
Kidney Precision Medicine Project
RECRUITING
-
Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol
COMPLETED · Phase 2
-
Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia